Weight Loss
14
 min read

Does Celsius Help With Visceral Fat?

Written by
Bolt Pharmacy
Published
13/10/2026
Last Updated

Does Celsius help with visceral fat? It is a question many people ask after seeing the drink marketed as a metabolism-boosting, fat-burning beverage. Celsius contains caffeine and green tea extract, ingredients with some evidence for modest effects on fat oxidation, but the picture is more nuanced than the branding suggests. This article examines what visceral fat is, what Celsius actually contains, what the clinical evidence does and does not support, and what strategies are genuinely effective for reducing visceral adiposity safely.

Summary: Celsius is unlikely to meaningfully reduce visceral fat on its own; its caffeine and green tea extract may modestly boost fat oxidation, but no clinical trials confirm a specific effect on visceral adiposity.

  • Visceral fat surrounds abdominal organs, releases inflammatory chemicals and raises the risk of type 2 diabetes and cardiovascular disease.
  • Celsius contains approximately 200 mg of caffeine per can plus green tea catechins (EGCG), which are its pharmacologically active ingredients.
  • Caffeine can transiently raise resting energy expenditure by 3 to 11 percent, but tolerance develops in habitual consumers, limiting sustained benefit.
  • No clinical trials have tested Celsius specifically for visceral fat reduction using imaging such as MRI or CT scanning.
  • Each can provides around 200 mg of caffeine; EFSA considers up to 400 mg daily safe for healthy adults, but pregnant women should limit intake to 200 mg per day.
  • Sustained visceral fat reduction requires calorie-controlled eating, regular aerobic and resistance exercise, adequate sleep and stress management.

What is visceral fat and why does it matter for your health?

Visceral fat is metabolically active fat stored deep in the abdominal cavity that releases inflammatory chemicals into the portal circulation, raising the risk of insulin resistance, type 2 diabetes and cardiovascular disease. A waist circumference above 94 cm in men or 80 cm in women indicates increased metabolic risk.

Visceral fat is the metabolically active fat stored deep within the abdominal cavity, surrounding organs such as the liver, pancreas and intestines, and it carries greater health risks than subcutaneous fat stored just beneath the skin. Unlike the fat you can pinch at the waist, visceral fat releases inflammatory chemicals and fatty acids directly into the portal circulation, which can contribute to insulin resistance, raised blood pressure, dyslipidaemia and an increased risk of type 2 diabetes and cardiovascular disease.

NICE guidance on obesity and cardiometabolic risk recognises that waist circumference is a useful proxy for visceral adiposity. In general, a waist measurement above 94 cm in men or above 80 cm in women is associated with increased metabolic risk, and measurements above 102 cm in men or 88 cm in women indicate substantially higher risk, though these thresholds vary by ethnicity (WHO guidance provides ethnicity-specific cut-offs).[1] UK guidance increasingly also recommends using waist-to-height ratio as a complementary measure of central adiposity risk: a ratio above 0.5 is generally considered to indicate elevated risk in adults, and this measure may be more informative across different ethnic groups than fixed waist-circumference thresholds alone.

Visceral fat accumulates through a combination of excess calorie intake, physical inactivity, poor sleep, chronic stress and genetic predisposition. Because it is hormonally active, it can create a self-reinforcing cycle: elevated cortisol, for example, promotes further visceral deposition. Reducing visceral fat through sustained lifestyle change has well-documented benefits for blood glucose control, blood pressure and cardiovascular risk markers, making it a meaningful clinical target rather than simply a cosmetic concern.

Strategy Evidence Base Effect on Visceral Fat Key Considerations
Celsius (caffeine plus green tea extract) Short-term pharmacological studies, Cochrane review on green tea; no trials using Celsius directly No robust evidence of visceral fat reduction; modest, transient effect on fat oxidation only Tolerance develops with regular use; 200 mg caffeine per can; not MHRA-authorised for any therapeutic use
Aerobic exercise (brisk walking, cycling, swimming) Strong; supported by UK Chief Medical Officers physical activity guidelines Meaningful reductions in visceral fat, even without significant total weight loss At least 150 minutes of moderate-intensity activity per week recommended
Resistance training Good; improves insulin sensitivity and resting metabolic rate Supports visceral fat reduction by improving metabolic profile Combine with aerobic exercise for best outcomes
Calorie-controlled diet (lower refined carbohydrates, higher fibre and protein) Strong; associated with reduced visceral adiposity in multiple studies Direct reduction in visceral fat with sustained dietary change Reduce ultra-processed foods and added sugars; increase unsaturated fats
Improved sleep (7 to 9 hours per night) Good; supported by NHS guidance on sleep and metabolic health Reduces cortisol and ghrelin, limiting visceral fat accumulation Poor sleep raises cortisol, which preferentially drives visceral deposition
Stress reduction Moderate; chronic stress elevates cortisol, promoting visceral deposition Lowering cortisol reduces preferential visceral fat storage Mindfulness, psychological support and lifestyle changes all relevant
NICE-recommended pharmacotherapy (semaglutide or tirzepatide) Strong; NICE technology appraisals NG246 and related guidance Clinically significant reductions in body weight and visceral adiposity Eligible if BMI 35 or above (32.5 in certain ethnic groups) with comorbidity; subject to ICB commissioning

What is Celsius and what does it actually contain?

Celsius is a commercially produced energy drink, not a licensed medicine, whose active ingredients are approximately 200 mg of caffeine per can and green tea catechins (EGCG). It has not been evaluated by NICE or the MHRA for any therapeutic indication.

Celsius is a commercially produced energy drink, originating in the United States, that is marketed as a fitness and metabolism-support beverage. In the UK, energy drinks are regulated as foods under UK food law, with oversight from the Food Standards Agency (FSA). They are not licensed medicines and are not authorised by the MHRA for any therapeutic indication. Any claims Celsius makes about fat burning or metabolism should be understood in that context.

The drink's formulation varies by product line and flavour. A standard Celsius can is reported by the manufacturer to contain approximately 200 mg of caffeine per can, though readers should check the label of the specific product they purchase, as caffeine content can vary. Typical ingredients across the range include:

  • Caffeine (approximately 200 mg per can, broadly equivalent to two strong cups of coffee)

  • Green tea extract (a source of catechins, particularly epigallocatechin gallate, or EGCG)

  • Guarana extract (an additional source of caffeine)

  • Ginger extract

  • B vitamins (including B6, B12, niacin, pantothenic acid and riboflavin)

  • Vitamin C

  • Chromium

  • Taurine

The combination of caffeine and green tea catechins is the pharmacologically active core of the product. The remaining ingredients are present in amounts that, at concentrations typically found in a single can, are unlikely to produce clinically meaningful effects on fat metabolism based on current evidence. Celsius is not a prescription product and has not been evaluated by NICE or the MHRA for any therapeutic indication.

What does the evidence say about caffeine and fat metabolism?

Caffeine modestly raises resting energy expenditure and promotes lipolysis, but no trials have tested Celsius specifically for visceral fat reduction. Any metabolic effect is small, transient and blunted by tolerance in habitual consumers.

Caffeine has a modest, well-documented effect on fat oxidation and resting metabolic rate, but there is no robust clinical evidence that Celsius specifically reduces visceral fat in humans. Caffeine acts as an adenosine receptor antagonist and stimulates the sympathetic nervous system, increasing the release of catecholamines such as adrenaline.[6][5] This promotes lipolysis, the breakdown of stored triglycerides into free fatty acids, and can transiently raise resting energy expenditure by roughly 3 to 11 percent in the short term, according to published pharmacological reviews and meta-analyses of caffeine supplementation studies.[4][5]

Green tea catechins, particularly EGCG, may have an additive effect on fat oxidation when combined with caffeine. Some randomised controlled trials have shown small reductions in body weight and waist circumference with green tea extract supplementation, though effect sizes are modest and clinical significance is debated. A Cochrane review on green tea preparations for weight loss found only small, statistically non-significant reductions in body weight compared with control conditions.[7] More recent meta-analyses have similarly found that any effects on body weight and waist circumference are modest. The evidence base does not include trials using Celsius as the intervention.

Critically, none of this evidence is specific to visceral fat as measured by imaging techniques such as MRI or CT scanning, and none of it is specific to Celsius as a product. Thermogenic effects from caffeine are blunted in habitual consumers due to tolerance, meaning regular drinkers are unlikely to sustain even the modest metabolic benefits seen in short-term studies. Any effect on fat metabolism from Celsius is likely to be small, transient and insufficient on its own to produce meaningful reductions in visceral adiposity without accompanying dietary and physical activity changes.

Are there any safety concerns with drinking Celsius regularly?

Each Celsius can contains approximately 200 mg of caffeine, so consuming more than one daily risks exceeding safe limits and can cause palpitations, raised blood pressure and anxiety. People who are pregnant, have cardiovascular disease or take CYP1A2-inhibiting medicines should exercise particular caution.

Drinking Celsius regularly carries safety considerations that are relevant to a UK audience, particularly because each standard can contains approximately 200 mg of caffeine, and some people consume more than one can per day. The European Food Safety Authority (EFSA) scientific opinion on caffeine (2015) considers a daily caffeine intake of up to 400 mg safe for healthy adults, but recommends that pregnant women limit intake to 200 mg per day.[8] NHS guidance on caffeine in pregnancy supports this limit. Exceeding these thresholds is associated with anxiety, insomnia, palpitations, raised blood pressure and, in susceptible individuals, cardiac arrhythmias. It is also worth accounting for caffeine from all sources, including coffee, tea and pre-workout products, when assessing total daily intake.

People with the following conditions should exercise particular caution or avoid high-caffeine drinks altogether:

  • Cardiovascular disease or hypertension

  • Anxiety disorders or panic disorder

  • Gastro-oesophageal reflux disease (GORD)

  • Pregnancy or breastfeeding

  • Those taking medicines that interact with caffeine, including medicines that inhibit the CYP1A2 enzyme (such as fluvoxamine), theophylline and certain antibiotics such as ciprofloxacin, which can raise caffeine blood levels significantly[10]

The high caffeine content also raises concerns about use in children and adolescents. UK Chief Medical Officers and NHS guidance advise that energy drinks are not appropriate for children and young people.[11] Combining Celsius with alcohol or other stimulants increases cardiovascular risk further.

If you experience chest pain, a rapid or irregular heartbeat, severe headache or significant anxiety after consuming high-caffeine drinks, contact your GP. For urgent symptoms such as chest pain with breathlessness or collapse, call 999 immediately. Suspected adverse reactions to food supplements or energy drinks can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

What else can help reduce visceral fat alongside diet and lifestyle?

Aerobic exercise of at least 150 minutes per week, resistance training, a diet low in refined carbohydrates and ultra-processed foods, adequate sleep and stress reduction have the strongest evidence for reducing visceral fat. NICE-recommended pharmacological treatments such as semaglutide or tirzepatide may be appropriate for eligible individuals.

Sustained reductions in visceral fat are best achieved through a combination of calorie-controlled eating, regular physical activity, improved sleep and stress management, rather than through any single drink or supplement. NICE guidance on weight management (NG246 and related technology appraisals) supports a structured approach that includes behavioural support alongside dietary and activity changes.

The following strategies have the strongest evidence base for reducing visceral adiposity:

  • Aerobic exercise: moderate-intensity activity such as brisk walking, cycling or swimming for at least 150 minutes per week, as recommended by UK Chief Medical Officers' physical activity guidelines for adults, is associated with meaningful reductions in visceral fat even without significant changes in total body weight[12][13]

  • Resistance training: building lean muscle mass improves insulin sensitivity and resting metabolic rate, both of which support visceral fat reduction

  • Dietary pattern: a diet lower in refined carbohydrates, added sugars and ultra-processed foods, and higher in fibre, lean protein and unsaturated fats, is associated with reduced visceral adiposity

  • Sleep: consistently poor sleep raises cortisol and ghrelin levels, promoting visceral fat accumulation; aiming for 7 to 9 hours per night is supported by NHS guidance[18]

  • Stress reduction: chronic psychological stress elevates cortisol, which preferentially drives visceral fat deposition

For people with a BMI of 35 or above (or 32.5 or above in certain ethnic groups) and a weight-related comorbidity, NICE-recommended pharmacological treatments such as semaglutide (Wegovy, available in doses up to 2.4 mg weekly, with a 7.2 mg weekly dose also licensed in the UK) or tirzepatide (Mounjaro) may be considered as part of a specialist weight management programme, subject to NICE technology appraisal criteria and local Integrated Care Board commissioning decisions. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options may be discussed. Your GP can advise on referral pathways and whether you meet the criteria for NHS-commissioned treatment through your local Integrated Care Board.

Scientific References

  1. .
  2. .
  3. .
  4. .
  5. .
  6. .
  7. .
  8. .
  9. .
  10. .
  11. .
  12. .
  13. .
  14. .
  15. .
  16. .
  17. .
  18. .

Frequently Asked Questions

Can drinking Celsius reduce visceral fat?

There is no clinical trial evidence that Celsius specifically reduces visceral fat. Its caffeine and green tea extract may modestly increase fat oxidation, but any effect is small, transient and insufficient on its own without dietary and exercise changes.

Is it safe to drink Celsius every day in the UK?

Healthy adults can consume up to 400 mg of caffeine daily according to EFSA guidance, but one Celsius can already provides around 200 mg, so drinking multiple cans or combining it with other caffeine sources can exceed safe limits and cause palpitations, anxiety and raised blood pressure.

What is the most effective way to reduce visceral fat?

The strongest evidence supports a combination of at least 150 minutes of moderate aerobic exercise per week, resistance training, a diet lower in refined carbohydrates and ultra-processed foods, adequate sleep and stress management. For eligible individuals, NICE-recommended treatments such as semaglutide or tirzepatide may also be considered.


Disclaimer & Editorial Standards

The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.

The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.

Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.